Using personalized immune-humanized xenograft mouse models to predict immune checkpoint responses in malignant melanoma: potential and hurdles

被引：3
|
作者：
Helleday, T. [1 ,2 ]
机构：
[1] Univ Sheffield, Dept Oncol & Metab, Weston Pk Canc Ctr, Sheffield, S Yorkshire, England
[2] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷 / 02期
基金：
瑞典研究理事会;
关键词：
PD-1; BLOCKADE;
D O I：
10.1016/j.annonc.2019.11.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：167 / 168
页数：2
相关论文
共 50 条
  • [1] Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models
    Ny, L.
    Rizzo, L. Y.
    Belgrano, V
    Karlsson, J.
    Jespersen, H.
    Carstam, L.
    Bagge, R. O.
    Nilsson, L. M.
    Nilsson, J. A.
    ANNALS OF ONCOLOGY, 2020, 31 (02) : 266 - 273
  • [2] Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models (vol 31, pg 266, 2020)
    Ny, L.
    Rizzo, L. Y.
    Belgrano, V.
    Karlsson, J.
    Jespersen, H.
    Carstam, L.
    Bagge, R. Olofsson
    Nilsso, L. M.
    Nilsson, J. A.
    ANNALS OF ONCOLOGY, 2020, 31 (05) : 663 - 663
  • [3] Immune checkpoint inhibitor responses in humanized mouse melanoma models using patient-derived xenografts
    Somasundaram, Rajasekharan
    Bequiri, Marilda
    Li, Ling
    Herlyn, Meenhard
    Kiernan, Meaghan
    Muthumani, Kar
    Choi, Hyeree
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [4] Immune checkpoint inhibitor responses in humanized mouse melanoma models using patient-derived xenografts.
    Somasundaram, Rajasekharan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [5] Modeling HBV infections and immune responses in humanized mouse models
    Dusseaux, M.
    Masse-Ranson, G.
    Darche, S.
    Ahodantin, J.
    Li, Y.
    Beaumont, E.
    Moreau, P.
    Neuveut, C.
    Soussan, P.
    Roingeard, P.
    Kremsdorf, D.
    Santo, J. D.
    Strick-Marchand, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S790 - S790
  • [6] Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses
    Yuen, Vincent Wai-Hin
    Chiu, David Kung-Chun
    Law, Cheuk-Ting
    Cheu, Jacinth Wing-Sum
    Chan, Cerise Yuen-Ki
    Wong, Bowie Po-Yee
    Goh, Chi-Ching
    Zhang, Misty Shuo
    Xue, Helen Do-Gai
    Tse, Aki Pui-Wah
    Zhang, Yan
    Lau, Henry Yee-Hin
    Lee, Derek
    Au-Yeung, Rex K. H.
    Wong, Chun-Ming
    Chak-Lui, Carmen
    JOURNAL OF HEPATOLOGY, 2023, 78 (02) : 376 - 389
  • [7] Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy
    Guo, Wenwen
    Zhang, Caiqin
    Qiao, Tianyun
    Zhao, Jumei
    Shi, Changhong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
    Jespersen, Henrik
    Lindberg, Mattias F.
    Donia, Marco
    Soderberg, Elin M. V.
    Andersen, Rikke
    Keller, Ulrich
    Ny, Lars
    Svane, Inge Marie
    Nilsson, Lisa M.
    Nilsson, Jonas A.
    NATURE COMMUNICATIONS, 2017, 8
  • [9] Humanized mouse models for preclinical evaluation of novel immune therapies, checkpoint inhibitors and immune cell engagers
    Stecklum, M.
    Brzezicha, B.
    Rhein, S.
    Walther, W.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S12 - S12
  • [10] Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
    Henrik Jespersen
    Mattias F. Lindberg
    Marco Donia
    Elin M. V. Söderberg
    Rikke Andersen
    Ulrich Keller
    Lars Ny
    Inge Marie Svane
    Lisa M. Nilsson
    Jonas A. Nilsson
    Nature Communications, 8
12345